Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Cyclic amines active against H. pylori in development at Takeda

May 7, 1998

FDA advisory committee recommends approval of drug combination for hepatitis C

May 6, 1998

Sagami presents new anti-H. pylori agents

May 6, 1998

YJA-20379, an H+/K+-ATPase inhibitor that inhibits H. pylori

May 1, 1998

Corvas/Schering-Plough HCV protease collaboration extended

May 1, 1998

Gastric prokinetic effects and safety of EM-574 in healthy subjects

April 30, 1998

Gastric prokinetic/antiemetic agents from Dainippon

April 28, 1998

Clinical trials of reformulated H-BIG completed

April 28, 1998

TAK-044 and its effects on liver injury and portal hypertension in rats

April 28, 1998

FDA advisory committee will meet to discuss Avakine NDA

April 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...